Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase

A.M. Bergman; H.M. Pinedo; A.P.M. Jongsma; M. Brouwer; V.W.T. van Ruiz van Haperen; G. Veerman; A. Leyva; S. Eriksson; G.J. Peters

doi:https://doi.org/10.1016/S0006-2952(98)00318-9

Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase

A.M. Bergman, H.M. Pinedo, A.P.M. Jongsma, M. Brouwer, V.W.T. van Ruiz van Haperen, G. Veerman, A. Leyva, S. Eriksson, G.J. Peters

Amsterdam UMC

Research output: Contribution to journal › Article › Academic › peer-review

76 Citations (Scopus)

Original language	English
Pages (from-to)	397-406
Journal	Biochemical Pharmacology
Volume	57
DOIs	https://doi.org/10.1016/S0006-2952(98)00318-9
Publication status	Published - 1999

Access to Document

https://doi.org/10.1016/S0006-2952(98)00318-9

Cite this

Bergman, A. M., Pinedo, H. M., Jongsma, A. P. M., Brouwer, M., van Ruiz van Haperen, V. W. T., Veerman, G., Leyva, A., Eriksson, S., & Peters, G. J. (1999). Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase. Biochemical Pharmacology, 57, 397-406. https://doi.org/10.1016/S0006-2952(98)00318-9

@article{a8208c47186d4026b638575b702c5499,

title = "Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase",

author = "A.M. Bergman and H.M. Pinedo and A.P.M. Jongsma and M. Brouwer and {van Ruiz van Haperen}, V.W.T. and G. Veerman and A. Leyva and S. Eriksson and G.J. Peters",

year = "1999",

doi = "https://doi.org/10.1016/S0006-2952(98)00318-9",

language = "English",

volume = "57",

pages = "397--406",

journal = "Biochemical Pharmacology",

issn = "0006-2952",

publisher = "Elsevier Inc.",

}

Bergman, AM, Pinedo, HM, Jongsma, APM, Brouwer, M, van Ruiz van Haperen, VWT, Veerman, G, Leyva, A, Eriksson, S & Peters, GJ 1999, 'Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase', Biochemical Pharmacology, vol. 57, pp. 397-406. https://doi.org/10.1016/S0006-2952(98)00318-9

Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase. / Bergman, A.M.; Pinedo, H.M.; Jongsma, A.P.M. et al.
In: Biochemical Pharmacology, Vol. 57, 1999, p. 397-406.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase

AU - Bergman, A.M.

AU - Pinedo, H.M.

AU - Jongsma, A.P.M.

AU - Brouwer, M.

AU - van Ruiz van Haperen, V.W.T.

AU - Veerman, G.

AU - Leyva, A.

AU - Eriksson, S.

AU - Peters, G.J.

PY - 1999

Y1 - 1999

U2 - https://doi.org/10.1016/S0006-2952(98)00318-9

DO - https://doi.org/10.1016/S0006-2952(98)00318-9

M3 - Article

SN - 0006-2952

VL - 57

SP - 397

EP - 406

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

ER -

Bergman AM, Pinedo HM, Jongsma APM, Brouwer M, van Ruiz van Haperen VWT, Veerman G et al. Decreased resistance to gemcitabine (2', 2'- difluorodeoxycytidine) of cytosine-arabinoside resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidne kinase. Biochemical Pharmacology. 1999;57:397-406. doi: https://doi.org/10.1016/S0006-2952(98)00318-9